Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: Correlative findings of active versus irreversible plaque disease

American Journal of Neuroradiology

Volumn 17, Issue 8, 1996, Pages 1539-1547

  Kimura, Hirohiko ^a,b   Grossman, Robert I ^a   Lenkinski, Robert E ^a   Gonzalez Scarano, Francisco ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Radiology   (Japan)

Author keywords

Magnetic resonance, magnetization transfer; Magnetic resonance, spectroscopy; Sclerosis, multiple

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN METABOLISM; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; BRAIN DISEASES; BRAIN EDEMA; CHOLINE; CHRONIC DISEASE; CREATINE; DEMYELINATING DISEASES; ENCEPHALITIS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTONS;

EID: 0029793367     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Balaban RS, Ceckler TL. Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q 1992;8:116-137
2. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10: 135-144
3. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491
4. Lexa FJ, Grossman RI, Rosenquist AC. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212
5. Richards T. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR Am J Roentgenol 1991;157:1073-1078
6. Arnold D, Matthews P, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990;14:154-159
7. Nadler JV, Cooper JR. N-acetyl-L-aspartic acid content of human neural tumorous and bovine peripheral nervous tissues. J Neurochem 1971;178:313-319
8. Koller KJ, Zaczek R, Coyle J. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1136-1142
9. MacGowan JC, Schnall MD, Leigh JS. Magnetization transfer imaging with pulsed off-resonance saturation: variation in contrast with saturation duty cycle. J Magn Reson Imaging 1994;4:79-82
10. Marion D, Ikura M, Bax A. Improved solvent suppression in one-and two-dimentional NMR spectra by convolution of time-domain data. J Magn Reson 1989;84:425-430
11. Rose LM, Richards TL, Petersen R, Perterson J, Hruby S, Alvord EC. Remitting-relapsing EAE in nonhuman primates: a valid model of multiple sclerosis. Clin Immunol Immunopathol 1991; 59:1-15
12. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1256
13. Miller DH, Austin SJ, Connelly A, Youl BD, Gadian DQ, McDonald WI. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 1991;337:58-59
14. Van Hecke P, Marchai G, Johannik K, et al. Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med 1991;18:199-206
15. Narayana PA, Wolinsky JS, Jackson EF, McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. J Magn Reson Imaging 1992;2:263-270
16. Koopmans RA, Li DK, Zhu G, Allen PS, Penn A, Paty DW. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet 1993;341:631-632
17. Davie CA, Hawkins CP, Barker GJ, et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993;341:630-631
18. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535-1543
19. 1H-NMR spectroscopy studies of brain. Neurosci Biobehav Rev 1989;13:23-31
20. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515
21. Allen IV, Mckeown SR. A histological, histochemical and biochemical of the macroscopically normal white matter in multiplesclerosis. J Neurol Sci 1979;41:81-91
22. Brenner RE, Munro PMG, Williams SCR, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-745
23. Hiehle JF, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994;32:285-293